StockNews.com Downgrades Edap Tms (NASDAQ:EDAP) to Sell

Edap Tms (NASDAQ:EDAP) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Monday.

Separately, HC Wainwright restated a “buy” rating and set a $19.00 price target on shares of Edap Tms in a research report on Thursday, August 29th.

Edap Tms Stock Up 1.3 %

Shares of NASDAQ EDAP opened at $2.39 on Monday. Edap Tms has a 52-week low of $2.27 and a 52-week high of $8.50. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 2.18. The business has a fifty day moving average of $2.79 and a two-hundred day moving average of $4.28. The stock has a market cap of $88.67 million, a PE ratio of -3.68 and a beta of 0.38.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.04). The firm had revenue of $16.97 million for the quarter, compared to the consensus estimate of $17.16 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. As a group, equities research analysts expect that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in EDAP. Commonwealth Equity Services LLC raised its stake in shares of Edap Tms by 5.9% in the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after acquiring an additional 4,000 shares during the last quarter. BNP Paribas Financial Markets boosted its stake in shares of Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 4,400 shares during the last quarter. Orion Capital Management LLC grew its position in shares of Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after buying an additional 6,600 shares during the period. Virtu Financial LLC bought a new stake in shares of Edap Tms during the first quarter worth approximately $82,000. Finally, Redhawk Wealth Advisors Inc. bought a new stake in shares of Edap Tms during the third quarter worth approximately $36,000. Institutional investors and hedge funds own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.